ARBUTUS BIOPHARMA CORP's ticker is ABUS and the CUSIP is 03879J100. A total of 97 filers reported holding ARBUTUS BIOPHARMA CORP in Q3 2023. The put-call ratio across all filers is 0.90 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $65,179 | -48.7% | 32,108 | -41.9% | 0.00% | – |
| Q2 2023 | $127,045 | +50.5% | 55,237 | +98.3% | 0.00% | – |
| Q1 2023 | $84,404 | +298.0% | 27,856 | +206.1% | 0.00% | – |
| Q4 2022 | $21,205 | +51.5% | 9,101 | +14.9% | 0.00% | – |
| Q3 2022 | $14,000 | -30.0% | 7,922 | +3.9% | 0.00% | – |
| Q2 2022 | $20,000 | -92.9% | 7,621 | -92.0% | 0.00% | – |
| Q1 2022 | $282,000 | -38.4% | 94,806 | -19.4% | 0.00% | – |
| Q4 2021 | $458,000 | -74.8% | 117,691 | -72.3% | 0.00% | – |
| Q3 2021 | $1,820,000 | +15066.7% | 424,422 | +10710.5% | 0.00% | – |
| Q2 2021 | $12,000 | -20.0% | 3,926 | -16.0% | 0.00% | – |
| Q1 2021 | $15,000 | -11.8% | 4,676 | -0.8% | 0.00% | – |
| Q4 2020 | $17,000 | +6.2% | 4,712 | -11.7% | 0.00% | – |
| Q3 2020 | $16,000 | +220.0% | 5,336 | +84.0% | 0.00% | – |
| Q2 2020 | $5,000 | +66.7% | 2,900 | 0.0% | 0.00% | – |
| Q1 2020 | $3,000 | -62.5% | 2,900 | -3.3% | 0.00% | – |
| Q4 2019 | $8,000 | +60.0% | 3,000 | 0.0% | 0.00% | – |
| Q3 2019 | $5,000 | -50.0% | 3,000 | -40.2% | 0.00% | – |
| Q2 2019 | $10,000 | -94.8% | 5,014 | -90.7% | 0.00% | – |
| Q1 2019 | $193,000 | +19.9% | 53,938 | +28.6% | 0.00% | – |
| Q4 2018 | $161,000 | -75.0% | 41,937 | -38.4% | 0.00% | – |
| Q3 2018 | $644,000 | +90.0% | 68,063 | +46.9% | 0.00% | – |
| Q2 2018 | $339,000 | +2160.0% | 46,326 | +1443.7% | 0.00% | – |
| Q1 2018 | $15,000 | -11.8% | 3,001 | -11.8% | 0.00% | – |
| Q4 2017 | $17,000 | -19.0% | 3,401 | +0.0% | 0.00% | – |
| Q3 2017 | $21,000 | +61.5% | 3,400 | -8.0% | 0.00% | – |
| Q2 2017 | $13,000 | +18.2% | 3,695 | +4.8% | 0.00% | – |
| Q1 2017 | $11,000 | +37.5% | 3,525 | +10.3% | 0.00% | – |
| Q4 2016 | $8,000 | -20.0% | 3,195 | +6.7% | 0.00% | – |
| Q3 2016 | $10,000 | 0.0% | 2,995 | 0.0% | 0.00% | – |
| Q2 2016 | $10,000 | -16.7% | 2,995 | 0.0% | 0.00% | – |
| Q1 2016 | $12,000 | -7.7% | 2,995 | +0.8% | 0.00% | – |
| Q4 2015 | $13,000 | -23.5% | 2,970 | +6.1% | 0.00% | – |
| Q3 2015 | $17,000 | – | 2,800 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| JACOB ASSET MANAGEMENT OF NEW YORK LLC | 260,000 | $866,000 | 0.34% |
| RTW INVESTMENTS, LP | 5,978,355 | $19,908,000 | 0.31% |
| GSA CAPITAL PARTNERS LLP | 309,839 | $1,032,000 | 0.17% |
| QCM Cayman, Ltd. | 12,728 | $42,000 | 0.13% |
| COWEN AND COMPANY, LLC | 486,717 | $1,621,000 | 0.11% |
| Hudson Bay Capital Management LP | 1,400,000 | $4,662,000 | 0.06% |
| Kerrisdale Advisers, LLC | 208,150 | $693,000 | 0.05% |
| Secure Asset Management, LLC | 10,000 | $33,000 | 0.02% |
| PDT Partners, LLC | 72,500 | $241,000 | 0.02% |
| Point72 Asset Management, L.P. | 1,037,700 | $3,456,000 | 0.02% |